It's the first monoclonal antibody combination product (casirivimab and imdevimab) approved for use in the prevention and treatment of acute infection from CORONAVIRUS (SARS-CoV-2). Monoclonal antibodies are man-made proteins that act like natural human antibodies in the immune system.
RONAPREVE won't be available to everyone, and isn't intended to replace vaccination. Administration is intravenous or via subcutaneous injection. gov.uk/government/publicati...
Patient info leaflet gov.uk/government/publicati...
Ronapreve for prophylaxis and treatment of covid-19, BMJ bmj.com/content/374/bmj.n2136